Creative Biolabs Provides Full-Fledged Solutions for Progressive Exosome Research
Summary
"Were determined to build a one-stop pipeline to provide intuitive outcomes for our clients, thereby allocating their efforts and costs appropriately," according to a specialist at Creative Biolabs. "The accuracy of studies utilizing exosomes as both drug carriers and biomarkers largely depends on substance purity that must undergo strict purification procedures to eliminate non-exosomal proteins and diminish co-purification, which has also become the initial step for almost any project. Meanwhile, exosome ultracentrifugation and microfiltration, size exclusion chromatography (SEC), and immunoaffinity capture are tactics that Creative Biolabs has mastered to achieve the most reliable results. CROs like Creative Biolabs are also expanding their service scopes, with the aim to discover every therapeutic and diagnostic target involving exosomes. Not to mention our enthusiasm to keep pace with industry trends enables us to constantly upgrade service protocols and product portfolios.